Berkshire Buys More DaVita

BERKSHIRE HATHAWAYWarren Buffett’s Berkshire Hathaway Inc. (NYSE:BRK.A) (NYSE:BRK.B) has continued buying shares of DaVita Inc. (NYSE:DVA) in the month of October, including a purchase of over 60,000 shares on October 16th. Berkshire had initiated its position in the company in the fourth quarter of 2011, with 2.7 million shares in its portfolio at the end of the year, and then increased its stake further in the first half of the year. At the end of June, the holding company’s 9.3 million shares gave it nearly $1 billion worth of the stock, which has risen 13% since that time and now has a market cap of $10.5 billion. Research more buying and selling from Warren Buffett.

DaVita Inc. is a provider of kidney dialysis services, both in outpatient centers and as inpatient services in hospitals. Revenue was up 16% in the second quarter compared to the same period in 2011, and increased at a similar rate in the first quarter of the year (sales increased 3% on a q/q basis). Operating expenses were also higher, and a legal proceeding contingency caused operating income (as well as net income) to be about flat. Without that contingency, the second quarter would have shown about the same increase in operating income that the company saw in the first quarter. Including it, earnings per share for the first half of 2012 rose to $2.46 compared to $1.99 a year earlier. Therefore, it appears that DaVita’s operations are doing quite well.

DaVita’s trailing P/E is 20, but that’s likely skewed up a point or two by the contingency which reduced the company’s earnings in the second quarter. Annualizing the first quarter’s $1.47 in earnings generates a P/E of 19, and note that revenue- though not necessarily operating income ex-contingency- was higher in the second quarter. The company trades at 16 times forward earnings estimates.

Buffett isn’t the only notable investor who likes DaVita Inc.- Tiger Cubs have started to sniff around as well. According to our database of 13F filings, Andreas Halvorsen’s Viking Global more than doubled its own position in the stock during the second quarter and closed June with a total of 3.2 million shares (find more stocks that Viking Global owned). Fellow Tiger Cub Stephen Mandel, who manages Lone Pine Capital, initiated a position of 3 million shares at his own fund (see more stock picks from Stephen Mandel and Lone Pine Capital).

DaVita’s peers include other specialized health care services providers such as Mednax Inc. (NYSE:MD), which provides neonatal care; HEALTHSOUTH Corp. (NYSE:HLS), which rehabilitates patients suffering from strokes or neurological problems; Acadia Healthcare Company Inc (NASDAQ:ACHC), which operates behavioral health centers; and orthotic and prosthetic care company Hanger Inc (NYSE:HGR). DaVita is generally priced at a premium to these peers, with Acadia being the exception: that company is unprofitable on a trailing basis, and trades at 24 times analyst consensus for 2013. It has been seeing very strong growth recently- up 61% in its most recent quarter compared to the same period in the previous year- and if it can continue that growth and deliver positive earnings than its valuation may make sense.

The other three peers all trade at forward P/E multiples in the 13-14 range, which as we’ve mentioned is something of a discount. They also showed considerable earnings growth in the second quarter versus the same period in 2011, with HealthSouth doubling its net income, and grew revenues modestly as well (though at lower rates than DaVita did). On an absolute basis, a P/E in that range given recent growth is quite attractive, but the same is the case for DaVita.

There’s little apparent difference in the value opportunity in these companies relative to each other, as the peers with lower growth rates seem to carry an appropriately lower multiple on their earnings. Therefore, an investor should pick whichever healthcare specialty they believe has the best prospects.

Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 10 Largest Pharmaceutical Companies In the World

The 10 Most Expensive Android Apps

The 9 Most Expensive Designer Bags in the World

The 7 Most Expensive Real Estate in the World

The 10 Most Expensive eBay Items Ever Sold

The 10 Most Expensive iPhone Apps

The 9 Most Expensive Designer Shoes in the World

The 10 Most Expensive Cigarette Brands

The 10 Most Expensive Law Schools in the US

The 10 Best Wall Street Movies

The 10 Most Expensive Golf Clubs Ever Sold

The 10 Most Expensive Golf Memberships

The 10 Best Disney Characters Ever Created

The 8 Best Foods for Gaining Weight

The 10 Most Expensive Colleges in the World

The 7 Most Memorable Ad Campaigns of All Time

The 7 Most Expensive High Schools in the World

The 10 Electric Vehicles with the Longest Range

The 10 Cities with the Worst Drivers in the World

The 10 Most Expensive Dresses Ever Created

10 Islands to Visit Before You Die

10 Famous Celebrities Who Needed Rehab

The 15 Countries with the Largest Oil Reserves

The 10 Most Overused Excuses in the World

The 5 Best iOS Apps You Can’t Get on Android

5 Companies Damaged By Social Media Blunders

The 10 Most Legendary Blues Songs

The 10 Most Lawless Places in the World

4 Reasons China is a Threat to the US

The 17 Most Sugary Drinks in the World

The 10 Most Ruthless Rulers in History

The 10 Greatest Generals in History

Top 8 Travel Destinations for 2015

The 10 Safest Dog Breeds for Children

The 10 Most Stolen Vehicles in the US

The 7 Most Expensive Celebrity Weddings

The 10 Best LoL Teams in the World

Top 10 Worst Marketing Campaigns Ever Produced

Top 5 Diets that Help You Lose Weight

The 10 Best Ways to Stay Awake

7 Artists That Switched Musical Genres

The 10 Most Expensive Cities to Live in New Jersey

The 10 Best High Schools in New York

The 10 Countries With the Least Gender Inequality

The 6 Biggest Musician-Manager Feuds

The 10 Countries with the Cheapest Gas Prices

The 7 Most Theatrical Bands of All Time

The 8 Worst Band Breakups of All Time

The 10 Most Important South American Leaders

The 7 Most Successful Casting Show Winners

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!